Global Minimally Invasive Surgical Instruments Market, by Application

According to research report the minimally invasive surgical instruments market is projected to reach USD 21.47 Billion by 2021 from USD 13.89 Billion in 2016, at a CAGR of 9.1%.

• Cardiothoracic Surgery
• Gastrointestinal surgery
• Orthopedic Surgery
• Gynecological Surgery
• Vascular Surgery
• Cosmetic/Bariatric Surgery
• Urological Surgery
• Other applications (ENT/Respiratory Surgery, Neurological Surgery, Dental Surgery, and Pediatric Surgery)

Benefits of minimally invasive surgeries over traditional open surgeries; reduction in healthcare costs and time; increasing number of surgeries among the aging population; increasing prevalence of lifestyle disorders; and technological advancements are key factors expected to drive the growth of the minimally invasive surgical instruments market. Increasing awareness of technologically advanced MIS instruments & procedures and emerging markets provide significant growth opportunities for the market.

Benefits of minimally invasive surgeries over traditional procedures to drive the market growth during the forecast period

Based on application, the market is segmented into cardiothoracic surgery, cosmetic surgery/bariatric surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, vascular surgery, urological surgery, and others. The others segment is further segmented into ENT/respiratory surgery, neurological surgery, dental surgery, and pediatric surgery. In 2015, the cardiothoracic surgery segment accounted for the largest share of the global minimally invasive surgical instruments market. The rising prevalence of cardiac diseases in developed as well as developing countries, increasing demand of minimally invasive surgeries, growth in aging population, and technological developments are the major factors driving the growth of the MIS instruments market for cardiothoracic surgeries.